Demet Turan

Demet Turan

Auto-generated profile, based on publicly available information

Demet Turan


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2020 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
MDMustafa Düger
Mustafa Düger
ESEkrem Seyhan
Ekrem Seyhan
MGMehmet Zeki Günlüoğlu
Mehmet Zeki Günlüoğlu
MBMustafa Bolatkale
Mustafa Bolatkale
MÖMehmet Akif Özgül
Mehmet Akif Özgül
GÜGÖZDE ÜLFER
GÖZDE ÜLFER

26 February 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
ETElif Tanriverdi̇
Elif Tanriverdi̇
MÇMustafa Çörtük
Mustafa Çörtük
BYBinnaz Zeynep Yildirim
Binnaz Zeynep Yildirim
ECEfsun Gonca Uğur Chousein
Efsun Gonca Uğur Chousein
DTDemet Turan
Demet Turan
EÇErdoğan Çetinkaya
Erdoğan Çetinkaya
New treatment regimens for COVID-19, which threatened the world recently, continue to be investigated. Although some of the treatments are promising, it is thought to be early to clearly state that there is definitive treatment. Experiences and treatment protocols studies coming from the centers are still very important. The aim of this study is to evaluate factors affecting the treatment process in the first cases followed in our clinic. The consecutive hospitalized patients with COVID-19 pneumonia were analyzed in this retrospective and cross-sectional study. Datas were recorded from the electronic and written files of patients. Eighty three patients were evaluated. The median age was 50±15 years. Fourty eight (57.8%) patients had one or more comorbidities. The most common comorbidity was hypertension. The most common symptom was cough in 58 patients (70%). The overall mortality was 15% and 85% of the patients were discharged. The time between the onset of symptoms and hospitalization was statistically significantly longer in deceased patients (p=0,039). Age, D-Dimer, troponin, creatine kinase (CK), CK-MB, ferritin, procalcitonin, and neutrophil to lymphocyte ratio were statistically significantly higher in deceased patients than survivor patients. Performed subgroup analysis, in the patients receiving azithromycin plus hydroxychloroquine and other antibiotics plus hydroxychloroquine, the duration of hospitalization was shorter in azithromycin group (p=0,027). Early treatment and early admission to the hospital can be crucial for the better treatment process. Combination therapy with azithromycin may be preferred in the first treatment choice because it can shorten the length of hospital stay.

10 March 2019 in Tuberk Toraks
Verified
Journal Article
Closed access
MÖMehmet Akif Özgül
Mehmet Akif Özgül
SGSule Gul
Sule Gul
EÇErdoğan Çetinkaya
Erdoğan Çetinkaya
DTDemet Turan
Demet Turan
GKGamze Kırkıl
Gamze Kırkıl
GÖGüler Özgül
Güler Özgül
Introduction: The most common cause of tracheal stenosis (TS) continues to be traumas according to the intubation and tracheostomy. Bronchoscopy is considered the gold standard for the detection and diagnosis of tracheobronchial pathology. There are several treatment options. We aimed to discuss our tracheal stenosis patients' treatment options, and their follow-up period. Materials and Methods: Consecutive referred patients between 2009 and 2018 presenting with TS were reviewed for the study. Demographic characteristics, localization, length and degree of stenosis, treatment techniques, postoperative complications, and survival were recorded for all patients. Results: A total of 110 patients included. The mean age was 53.7 +/- 16.7 (1698 years) years. Of 110 patients, 54 (49.1%) were female. Most common type of stenosis was complex stenosis (74.5%). Mechanical dilatation was applied to all patients. Stenotic regions of 22 (20%) patients were cut with bronchoscopic scissor. Tracheal stents were inserted into trachea of 49 (44.5%) patients. During follow-up period; 36 of 110 (32.7%) patients had surgical resection. Six of 36 (16.7%) patients died during follow-up period (one of them died during surgery), 17 (47.2%) patients had total recovery after surgery. Thirteen of 36 (36.1%) patients had restenosis after surgery. Conclusion: Tracheal stenosis is a process seen after postintubation or posttracheostomy frequently and it has a wide range of management modalities. Although, it is believed that surgery is the most efficient technique in cases without medical contraindications, we determined that endoscopic interventions can be alternative therapeutic options for inoperable patients. Patients must be followed-up after interventional therapies because complications, and restenosis can usually be seen.

31 December 2020 in Tuberk Toraks
Verified
Journal Article
Closed access
ECEfsun Gonca Uğur Chousein
Efsun Gonca Uğur Chousein
MÇMustafa Çörtük
Mustafa Çörtük
HCHalit Cınarka
Halit Cınarka
ETElif Tanrıverdi
Elif Tanrıverdi
DTDemet Turan
Demet Turan
MÖMehmet Akif Özgül
Mehmet Akif Özgül
Introduction: The Severe Acute Respiratory Syndrome (SARS-CoV-2) virus, which emerged from China and spread all over the world, has affected the world in every aspect and will do so in the foreseeable future. This study was carried out to investigate the possible aggravating effect of smoking on the prognosis of patients with COVID-19 pneumonia presenting with pulmonary involvement. Materials and Methods: 114 adult patients who received inpatient treatment in our clinic with the diagnosis of COVID-19 pneumonia between 11 March 2020 and 30 April 2020 were retrospectively included in the study; in particular, they were evaluated in terms of smoking history, severity of disease, need for NIMV and ICU admission, and mortality during their hospitalization. Results: The mean age of the 114 patients hospitalized with COVID-19 pneumonia was 51.14 +/- 14.97 (range 16-81), and 77 (67.5%) were male. Of the patients, 19 (15.9%) were active smokers, 23 were ex-smokers (20.1%), 72 (63.1%) non-smokers. The effect of smoking on the severity of the disease, length of hospitalization, need for non-invasive mechanical ventilation (NIMV) and intensive care unit (ICU) admission and mortality were not statistically significant. Conclusion: The rate of active smoking in patients hospitalized with COVID-19 is lower than the population average. In this study, no correlation was observed between smoking status and the severity, prognosis and mortality of the disease. Further studies with larger number of patients and case series are needed to better elucidate the relationship between smoking and COVID-19 and the pathophysiologic mechanisms of the effects of smoking on the natural history of COVID-19 pneumonia.

1 November 2020 in Heart & Lung
Verified
Journal Article
Closed access
EPEsra Pehlivan
Esra Pehlivan
EYEsra Yazar
Esra Yazar
ABArif Balcı
Arif Balcı
DTDemet Turan
Demet Turan
BDBarış Demirkol
Barış Demirkol
EÇErdoğan Çetinkaya
Erdoğan Çetinkaya

30 September 2019 in Tuberk Toraks
Verified
Journal Article
Closed access
DDDeniz Doğan
Deniz Doğan
DTDemet Turan
Demet Turan
MÖMehmet Akif Özgül
Mehmet Akif Özgül
EÇErdoğan Çetinkaya
Erdoğan Çetinkaya
Although metastasis of extrapulmonary solid organ malignant tumors to the lungs is very common, endobronchial metastases are very rare. The most common extrapulmonary tumors that make endobronchial metastases are breast, kidney and colorectal carcinomas. In this study, we retrospectively examined the data of eleven renal cell carcinoma patients who underwent endobronchial metastases in an eight-year period. Ten of the patients were male and the mean age was 55 ± 1 (41-71) years. The most common symptom was cough (45.5%, n= 5), on the other hand 18.2% (n= 2) of the patients had no complaints. Right bronchial system, left bronchial system and tracheal distribution rates of endobronchial lesions were 45.5% (n= 5), 63.6% (n= 7) and 27.3% (n= 3) respectively. The mean time from diagnosis of primary renal cell carcinoma to endobronchial metastases was 47.5 ± 32 (5.2-100.5) months. A total of twenty two interventional procedures were performed. All except one patient underwent endobronchial treatment. Argon plasma coagulation was most commonly used as the endobronchial metastases option (n= 10, 100%). The mechanical resection (n= 6, 60%), laser (n= 5, 50%), cryoextraction (n= 5, 50%) and cryotherapy (n= 4, 40%) methods were used other than argon plasma coagulation. The mean survival time was 19.4 ± 15.7 (3.2-40.5) months after endobronchial metastases and 54.0 ± 40.4 (8.7-107.6) months after renal cell carcinoma diagnosis. Extrathoracic malignancy that most metastasis to the airways is renal cell carcinoma. Endobronchial treatment procedures for endobronchial metastasis of renal cell carcinoma can be performed with low complication rates.